Correlation Between Salarius Pharmaceuticals and Basilea Pharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Basilea Pharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Basilea Pharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salarius Pharmaceuticals and Basilea Pharmaceutica AG, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Basilea Pharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Basilea Pharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Basilea Pharmaceutica.

Diversification Opportunities for Salarius Pharmaceuticals and Basilea Pharmaceutica

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Salarius and Basilea is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Basilea Pharmaceutica AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Basilea Pharmaceutica and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Basilea Pharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Basilea Pharmaceutica has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Basilea Pharmaceutica go up and down completely randomly.

Pair Corralation between Salarius Pharmaceuticals and Basilea Pharmaceutica

If you would invest  180.00  in Salarius Pharmaceuticals on November 5, 2024 and sell it today you would earn a total of  35.00  from holding Salarius Pharmaceuticals or generate 19.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Salarius Pharmaceuticals  vs.  Basilea Pharmaceutica AG

 Performance 
       Timeline  
Salarius Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Salarius Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Salarius Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Basilea Pharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Basilea Pharmaceutica AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Basilea Pharmaceutica is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Salarius Pharmaceuticals and Basilea Pharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salarius Pharmaceuticals and Basilea Pharmaceutica

The main advantage of trading using opposite Salarius Pharmaceuticals and Basilea Pharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Basilea Pharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Basilea Pharmaceutica will offset losses from the drop in Basilea Pharmaceutica's long position.
The idea behind Salarius Pharmaceuticals and Basilea Pharmaceutica AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Share Portfolio
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities